Popular Weight-Loss Drugs May Help Slow Aging

Topic: Health

Researchers found that a weight-loss medication called semaglutide may slow down some of the biological processes associated with aging. The study involved 108 adults living with HIV and used data from an earlier clinical trial to examine the effects of semaglutide on 'epigenetic clocks' that measure DNA methylation. Compared to those who received a placebo, participants treated with semaglutide showed slower aging.

The popularity of medications like Ozempic, Wegovy, and Rybelsus has grown in recent years due to their ability to help people lose weight, control blood sugar levels, and reduce the risk of heart disease. Now, researchers have discovered another potential benefit: slowing down some biological processes associated with aging.

A team of scientists from the University of California San Diego and collaborating institutions conducted a clinical trial involving 108 adults living with HIV-associated lipohypertrophy, a condition that causes excess fat to accumulate around the abdomen. Half of the participants received weekly semaglutide injections, while the rest were given a placebo for comparison.

To evaluate aging, the researchers used 'epigenetic clocks,' which measure DNA methylation, a pattern of chemical tags that influences how genes are switched on or off without changing the DNA sequence itself. These markers can provide insight into whether the body's cells appear to be aging faster or more slowly than expected.

The study found that compared to those who received a placebo, participants treated with semaglutide showed slower aging across multiple epigenetic clocks. This suggests that semaglutide may influence aging through several interconnected pathways, including reducing inflammation and improving metabolic health.

While the research focused on people living with HIV, the investigators believe the findings could have broader implications for understanding how to slow down biological aging in the general population.

Why It Matters

This study is important because it suggests that medications like semaglutide may be used to slow down biological aging. As India's population ages, finding ways to promote healthy aging and prevent age-related diseases will become increasingly crucial for public health.

Key Facts

• The study involved 108 adults living with HIV-associated lipohypertrophy.
• Participants were given either semaglutide injections or a placebo for comparison.
• Semaglutide may slow down biological aging by reducing inflammation and improving metabolic health.
• The study used 'epigenetic clocks' to measure DNA methylation and evaluate aging.
• The researchers believe the findings could have broader implications for understanding how to slow down biological aging in the general population.

Key Terms

Epigenetic clocks

Tools that measure DNA methylation, a pattern of chemical tags that influences gene expression.

Implications

This study is important because it suggests that medications like semaglutide may be used to slow down biological aging. As India's population ages, finding ways to promote healthy aging and prevent age-related diseases will become increasingly crucial for public health.